- Page 1 and 2: Greenwich Academic Literature Archi
- Page 3 and 4: DECLARATION “I certify that this
- Page 5 and 6: ABBREVIATIONS ATR-FT-IR (attenuated
- Page 7 and 8: CONTENTS DECLARATION ..............
- Page 9 and 10: CHAPTER TWO .......................
- Page 11 and 12: CHAPTER FOUR ......................
- Page 13 and 14: TABLES Table 1.1: Relationship of i
- Page 15 and 16: FIGURES Figure 1.1: Molecular model
- Page 17 and 18: [Accessed; 24/05/2012]. ...........
- Page 19 and 20: Figure 4.2: In-vitro mucoadhesion m
- Page 21 and 22: CHAPTER ONE INTRODUCTION AND LITERA
- Page 23 and 24: freezing rate at the start of a lyo
- Page 25 and 26: aggregates may lead to an immunogen
- Page 27 and 28: Figure 1.1: Molecular model of seru
- Page 29 and 30: One of the greatest milestones in m
- Page 31: limited success. INS released in a
- Page 35 and 36: ioavailability of proteins using pe
- Page 37 and 38: 1.3.3.2 Factors affecting mucoadhes
- Page 39 and 40: Human salivary glands secrete 1000-
- Page 41 and 42: 1.4.2 The nasal route Nasal protein
- Page 43 and 44: 1.4.3 The pulmonary route The lungs
- Page 45 and 46: and enzymes from foods and beverage
- Page 47 and 48: (Veuillez et al., 2001; Nagai, 1986
- Page 49 and 50: 1.6.1 Chitosan Chitosan together wi
- Page 51 and 52: 1.6.3 Chitosan derivatives The exce
- Page 53 and 54: with increasing amounts of immobili
- Page 55 and 56: 1.6.6.3 Thiolated chitosans as matr
- Page 57 and 58: stability studies among others can
- Page 59 and 60: the product matrix, the vacuum of t
- Page 61 and 62: an oven at an appropriate temperatu
- Page 63 and 64: Several analytical procedures have
- Page 65 and 66: transmitting crystal with a high re
- Page 67 and 68: 1.8.4.2 Powder diffraction Powder X
- Page 69 and 70: 1.8.5.1 Interpreting DSC thermogram
- Page 71 and 72: (absorption in the range 260 to 320
- Page 73 and 74: Figure 1.26: Representation of SEM.
- Page 75 and 76: CHAPTER TWO FORMULATION DEVELOPMENT
- Page 77 and 78: have recommended annealing time of
- Page 79 and 80: Figure 2.1: Chemical structure of c
- Page 81 and 82: model proteins for buccal delivery.
- Page 83 and 84:
microemulsion formulation containin
- Page 85 and 86:
Table 2.2: Details of consumables u
- Page 87 and 88:
chitosan was stirred continuously f
- Page 89 and 90:
Table 2.5: Lyophilisation cycles wi
- Page 91 and 92:
a b c d Figure 2.6: Photographs of
- Page 93 and 94:
simple one step coupling reaction i
- Page 95 and 96:
2.3.5 Lyophilisation The primary dr
- Page 97 and 98:
The foremost implication of these f
- Page 99 and 100:
3.2 Materials and methods 3.2.1 Mat
- Page 101 and 102:
were analysed with Agilent Chemstat
- Page 103 and 104:
previously tarred 70 µl aluminium
- Page 105 and 106:
3.2.13.2 Assay of BSA and INS conte
- Page 107 and 108:
A H1 (GluNAc) H3 -H6 NAc H2 (GluNH
- Page 109 and 110:
V o V e Intensity ElutionTime (min)
- Page 111 and 112:
c c r er % Transmittance 110 90 70
- Page 113 and 114:
during the xerogel preparation proc
- Page 115 and 116:
and without APR respectively. The r
- Page 117 and 118:
3.3.7 Physical stability of BSA and
- Page 119 and 120:
15 Circular dichroism (mdeg) 10 5 0
- Page 121 and 122:
Since no product melt-back was obse
- Page 123 and 124:
0.8 Absorbance ratio 595/450 0.7 0.
- Page 125 and 126:
A B Dialysed chitosan-BSA 100 µm 1
- Page 127 and 128:
High magnification SEM micrograph o
- Page 129 and 130:
BSA content (%) 100.0 80.0 60.0 40.
- Page 131 and 132:
conditions leads to protein hydroly
- Page 133 and 134:
3.4 Conclusions Analytical characte
- Page 135 and 136:
CHAPTER FOUR HYDRATION CAPACITY AND
- Page 137 and 138:
4.2.2.1 Effect of formulation proce
- Page 139 and 140:
substrate in order to select the op
- Page 141 and 142:
Table 4.3 Hydration capacity of xer
- Page 143 and 144:
4.3.2.1 Factors affecting mucoadhes
- Page 145 and 146:
impacted on the mucoadhesive proper
- Page 147 and 148:
and TG-chitosan xerogels. The chito
- Page 149 and 150:
PAF (N) TWA (mJ) Cohesiveness (mm)
- Page 151 and 152:
Annealed TG-chitosan xerogel simila
- Page 153 and 154:
that each model makes assumptions t
- Page 155 and 156:
independent difference and similari
- Page 157 and 158:
elease profiles plotted. Blank cont
- Page 159 and 160:
the second phase of the release pro
- Page 161 and 162:
100 Cummulative BSA Release (%) 80
- Page 163 and 164:
controlled drug release has been de
- Page 165 and 166:
Cummulative INS release (%) 100 80
- Page 167 and 168:
that of non-annealed dialysed chito
- Page 169 and 170:
Table 5.5: Release parameters obtai
- Page 171 and 172:
The effect of formulation processes
- Page 173 and 174:
Table 5.9: Model independent differ
- Page 175 and 176:
CHAPTER SIX PERMEATION STUDIES USIN
- Page 177 and 178:
6.2 Materials and Methods 6.2.1 Mat
- Page 179 and 180:
Permeation studies were conducted f
- Page 181 and 182:
fold increase in transport of BSA f
- Page 183 and 184:
Cumulative INS permeated (g/cm 2 )
- Page 185 and 186:
Average percentage viability was pl
- Page 187 and 188:
5.5 A TG-chitosan-INS permeation (E
- Page 189 and 190:
CHAPTER SEVEN SUMMARY CONCLUSIONS A
- Page 191 and 192:
was observed for dialysed and annea
- Page 193 and 194:
2. The long-term stability evaluati
- Page 195 and 196:
drug delivery systems via the bucca
- Page 197 and 198:
33. Bunte, H., Drooge, D.J., Ottjes
- Page 199 and 200:
56. Engles, L. 2005. Review and app
- Page 201 and 202:
(chitooligosaccharide derivatives)
- Page 203 and 204:
of single-point mutants of an amylo
- Page 205 and 206:
121. Koschier, F., Kostrubsky, V.,
- Page 207 and 208:
142. Liu, W., Wang, D.Q., Nail, S.
- Page 209 and 210:
160. Modi, P., Mihic, M. And Lewin,
- Page 211 and 212:
180. Pastore, A., Piemonte, F., Loc
- Page 213 and 214:
204. Robinson, J., R. 1990. Rationa
- Page 215 and 216:
224. Silva, C.A., Nobre, T.M., Pavi
- Page 217 and 218:
245. Tamburic, S., Graig, D.Q.M. 19
- Page 219 and 220:
265. Wang W. 2000. Lyophilisation a
- Page 221 and 222:
285. Zor, T., Selinger, Z. 1996. Li
- Page 223 and 224:
APPENDIX B: Manuscripts in preparat
- Page 225 and 226:
2. Accepted abstract for podium and
- Page 227 and 228:
4. Abstract # 43 awarded podium and
- Page 229 and 230:
6. Published abstract M1144 (2011).
- Page 231:
8. Published abstract W1470 (2010).